科学图书馆
-
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyPerkovic V, Jardine MJ, CREDENCE Trial Investigators. -
Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute WorkshopP Greenland, ED Michos, N Redmond et al.
-
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJ Borén, MJ Chapman, RM Krauss et al.
-
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER TrialMurphy SA, Pedersen TR, Gaciong ZA et al.
-
High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized StudyJ Henzel, C Kępka, M Kruk et al.
-
The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesisHI Chen , B Sharma, K Red-Horse et al.
-
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular DiseaseE Ajufo, CR Ayers, R Vigen et al.
-
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical TrialJS Hochman, HR Reynolds, S Bangalore et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
